Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by Population Health Research Institute.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Canadian Institutes of Health Research (CIHR)
World Health Organization
Dante Pazzanese Institute
Hospital das Clinicas de Ribeirao Preto/USP
Information provided by:
Population Health Research Institute
ClinicalTrials.gov Identifier:
NCT00123916
First received: July 21, 2005
Last updated: August 1, 2011
Last verified: June 2005